Gabriel Bsteh

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 199 publications

The Art of Sequencing Disease-Modifying Therapies in Multiple Sclerosis.

The Art of Sequencing Disease-Modifying Therapies in Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 16, 2026

Beyond pressure: Reframing idiopathic intracranial hypertension in the era of GLP-1 receptor agonists.

Beyond pressure: Reframing idiopathic intracranial hypertension in the era of GLP-1 receptor agonists.

Journal: Headache

Published: May 11, 2026

Reliability of Macular Ganglion Cell-Inner Plexiform Layer Thickness Measurements Across Scan Protocols in Spectral-Domain Optical Coherence Tomography.

Reliability of Macular Ganglion Cell-Inner Plexiform Layer Thickness Measurements Across Scan Protocols in Spectral-Domain Optical Coherence Tomography.

Journal: Journal of clinical medicine

Published: April 23, 2026

Assessing treatment response in multiple sclerosis.

Assessing treatment response in multiple sclerosis.

Journal: Current opinion in neurology

Published: April 08, 2026

Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases.

Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory Diseases.

Journal: JAMA neurology

Published: March 09, 2026

Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.

Integration of retinal layer thinning into NEDA-3 predicts disability progression in multiple sclerosis.

Journal: Journal of neurology

Published: March 09, 2026

The impact of OSCAR-IB quality control and manual segmentation on retinal atrophy rates in multiple sclerosis.

The impact of OSCAR-IB quality control and manual segmentation on retinal atrophy rates in multiple sclerosis.

Journal: Frontiers in neurology

Published: February 25, 2026

Serum and CSF neurofilament light chain and glial fibrillary acidic protein levels in idiopathic intracranial hypertension.

Serum and CSF neurofilament light chain and glial fibrillary acidic protein levels in idiopathic intracranial hypertension.

Journal: The journal of headache and pain

Published: February 01, 2026

Optic nerve assessments in MS diagnosis are worth the added implementation complexity: Yes.

Optic nerve assessments in MS diagnosis are worth the added implementation complexity: Yes.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: January 14, 2026

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: January 07, 2026

The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database study.

The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database study.

Journal: Journal of neurology

Published: December 15, 2025

Epidemiology, pharmacological treatment and invasive management of idiopathic intracranial hypertension in Austria: a nationwide, hospital-based, controlled analysis of insurance data.

Epidemiology, pharmacological treatment and invasive management of idiopathic intracranial hypertension in Austria: a nationwide, hospital-based, controlled analysis of insurance data.

Journal: The journal of headache and pain

Published: December 09, 2025

Showing 1-12 of 199

Last Updated: 09/26/2026